The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection
Open accessAbstract
Summary Viral protein homeostasis depends entirely on the machinery of the infected cell. Accordingly, viruses can illuminate the interplay between cellular proteostasis components and their distinct substrates. Here we define how the Hsp70 chaperone network mediates the dengue virus life cycle. Cytosolic Hsp70 isoforms are required at distinct steps of the viral cycle, including entry, RNA replication and virion biogenesis. Hsp70 function at each step is specified by nine distinct DNAJ cofactors. Of these, DnaJB11 relocalizes to virus-induced replication complexes to promote RNA synthesis, while DnaJB6 associates with capsid protein and facilitates virion biogenesis. Importantly, an allosteric Hsp70 inhibitor, JG40, potently blocks infection of different dengue serotypes in human primary blood cells without eliciting viral resistance or exerting toxicity to the host cells. JG40 also blocks replication of other medically-important flaviviruses including yellow fever, West Nile and Japanese encephalitis viruses. Thus, targeting host Hsp70 subnetworks provides a path for broad-spectrum antivirals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 5×
“Any of four serotypes causes a range of severe diseases; dengue fever (DF) is a debilitating acute flu-like illness, while dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), with about 500,000 cases annually, are lifethreatening diseases typified by vascular leakage and circulatory shock (Halstead, 2007)(…”
InfluentialMolecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
The HSP70 chaperone machinery: J proteins as drivers of functional specificity
Kampinga, H. H., & Craig, E. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2941 · Cited by 1,755
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Halstead, S. B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61687-0 · Cited by 1,287
Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites
Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C. K. E., Walther, P., Fuller, S. D., Antony, C., Krijnse-Locker, J., & Bartenschlager, R. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.007 · Cited by 1,091
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Rothman, A. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3014 · Cited by 770
Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation
Samsa, M. M., Mondotte, J. A., Iglesias, N. G., Assunção-Miranda, I., Barbosa-Lima, G., Da Poian, A. T., Bozza, P. T., & Gamarnik, A. V. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000632 · Cited by 586
DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING
Aguirre, S., Maestre, A. M., Pagni, S., Patel, J. R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R. S., Simon, V., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002934 · Cited by 521
Self-citationThe dependence of viral RNA replication on co-opted host factors
Nagy, P. D., & Pogany, J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2692 · Cited by 449
A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
Hageman, J., Rujano, M. A., van Waarde, M. A. W. H., Kakkar, V., Dirks, R. P., Govorukhina, N., Oosterveld-Hut, H. M. J., Lubsen, N. H., & Kampinga, H. H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.001 · Cited by 389
The role of mutational robustness in RNA virus evolution
Lauring, A. S., Frydman, J., & Andino, R. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3003 · Cited by 355
Self-citationTen years of dengue drug discovery: Progress and prospects
Lim, S. P., Wang, Q.-Y., Noble, C. G., Chen, Y.-L., Dong, H., Zou, B., Yokokawa, F., Nilar, S., Smith, P., Beer, D., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.013 · Cited by 350
Geller, R., Vignuzzi, M., Andino, R., & Frydman, J. (2007) · Genes & Development · doi:10.1101/gad.1505307 · Cited by 263
Self-citationDiversity in the origins of proteostasis networks — a driver for protein function in evolution
Powers, E. T., & Balch, W. E. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3542 · Cited by 247
Williamson, D. S., Borgognoni, J., Clay, A., Daniels, Z., Dokurno, P., Drysdale, M. J., Foloppe, N., Francis, G. L., Graham, C. J., Howes, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801627a · Cited by 227
Broad action of Hsp90 as a host chaperone required for viral replication
Geller, R., Taguwa, S., & Frydman, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.007 · Cited by 224
Self-citationRecruitment of Hsp70 chaperones: a crucial part of viral survival strategies
Mayer, M. P. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-004-0025-5 · Cited by 221
Antiviral Resistance and the Control of Pandemic Influenza
Lipsitch, M., Cohen, T., Murray, M., & Levin, B. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040015 · Cited by 209 · cited 1×
“The effectiveness of antivirals is severely limited by the emergence and spread of resistance (Lipsitch et al., 2007).”
Junjhon, J., Pennington, J. G., Edwards, T. J., Perera, R., Lanman, J., & Kuhn, R. J. (2014) · Journal of Virology · doi:10.1128/jvi.00118-14 · Cited by 200
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
Wang, A. M., Miyata, Y., Klinedinst, S., Peng, H.-M., Chua, J. P., Komiyama, T., Li, X., Morishima, Y., Merry, D. E., Pratt, W. B., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1140 · Cited by 186
Self-citationButrapet, S., Huang, C. Y.-H., Pierro, D. J., Bhamarapravati, N., Gubler, D. J., & Kinney, R. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3011-3019.2000 · Cited by 173
Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents
Li, X., Srinivasan, S. R., Connarn, J. N., Ahmad, A., Young, Z. T., Kabza, A. M., Zuiderweg, E. R. P., Sun, D., & Gestwicki, J. E. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400204n · Cited by 154
Self-citationDendritic Cells in Dengue Virus Infection: Targets of Virus Replication and Mediators of Immunity
Schmid, M., Diamond, M., & Harris, E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00647 · Cited by 154
Rodríguez-Madoz, J. R., Belicha‐Villanueva, A., Bernal‐Rubio, D., Ashour, J., Ayllón, J., & Fernández-Sesma, A. (2010) · Journal of Virology · doi:10.1128/jvi.01051-10 · Cited by 150
Self-citationMolecular Chaperones in Pathogen Virulence: Emerging New Targets for Therapy
Neckers, L., & Tatu, U. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.011 · Cited by 146
Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer
Li, X., Colvin, T. A., Rauch, J. N., Acosta‐Alvear, D., Kampmann, M., Dunyak, B. M., Hann, B. C., Aftab, B. T., Murnane, M., Cho, M. Y., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0650 · Cited by 138
Self-citationLysine 71 of the Chaperone Protein Hsc70 Is Essential for ATP Hydrolysis
O’Brien, M. C., Flaherty, K. M., & McKay, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15874 · Cited by 134
Hsp70 Protein Complexes as Drug Targets
Assimon, V. A., Gillies, A. T., Rauch, J. N., & Gestwicki, J. E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143699 · Cited by 128
Self-citationLimjindaporn, T., Wongwiwat, W., Noisakran, S., Srisawat, C., Netsawang, J., Puttikhunt, C., Kasinrerk, W., Avirutnan, P., Thiemmeca, S., Sriburi, R., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.070 · Cited by 122
Approaches to Refining Estimates of Global Burden and Economics of Dengue
Shepard, D. S., Undurraga, E. A., Betancourt-Cravioto, M., Guzmán, M. G., Halstead, S. B., Harris, E., Mudin, R. N., Murray, K. O., TAPIA-CONYER, R. C., & Gubler, D. J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003306 · Cited by 121
Balinsky, C. A., Schmeisser, H., Ganesan, S., Singh, K., Pierson, T. C., & Zoon, K. C. (2013) · Journal of Virology · doi:10.1128/jvi.00704-13 · Cited by 113
Dowd, K. A., Mukherjee, S., Kuhn, R. J., & Pierson, T. C. (2014) · Journal of Virology · doi:10.1128/jvi.01140-14 · Cited by 94
Yi, Z., Sperzel, L., Hörner, C., Bredenbeek, P. J., Lubick, K. J., Best, S. M., Stoyanov, C. T., Law, L. M. J., Yuan, Z., Rice, C. M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001255 · Cited by 83
Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus
Geller, R., Andino, R., & Frydman, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056762 · Cited by 73
Self-citationYe, J., Chen, Z., Zhang, B., Miao, H., Zohaib, A., Xu, Q., Chen, H., & Cao, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075188 · Cited by 71
Myopathy-causing Mutations in an HSP40 Chaperone Disrupt Processing of Specific Client Conformers
Stein, K. C., Bengoechea, R., Harms, M. B., Weihl, C. C., & True, H. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572461 · Cited by 54
Three decades of antiviral drugs
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2485 · Cited by 47
Cited by
In vivo aspects of protein folding and quality control
Balchin, D., Hayer-Hartl, M., & Hartl, F. U. (2016) · Science · doi:10.1126/science.aac4354 · Cited by 1,439
Rewiring cellular networks by members of the Flaviviridae family
Neufeldt, C. J., Cortese, M., Acosta, E. G., & Bartenschlager, R. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.170 · Cited by 409
Shah, P. S., Link, N., Jang, G. M., Sharp, P. P., Zhu, T., Swaney, D. L., Johnson, J. R., Von Dollen, J., Ramage, H. R., Satkamp, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.028 · Cited by 380
Self-citationBiochemistry and Molecular Biology of Flaviviruses
Barrows, N. J., Campos, R. K., Liao, K.-C., Prasanth, K. R., Soto-Acosta, R., Yeh, S.-C., Schott-Lerner, G., Pompon, J., Sessions, O. M., Bradrick, S. S., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00719 · Cited by 341
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Boldescu, V., Behnam, M. A. M., Vasilakis, N., & Klein, C. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.33 · Cited by 305
Metadata
- Authors
- Taguwa, S., Maringer, K., Li, X., Bernal-Rubio, D., Rauch, J. N., Gestwicki, J. E., Andino, R., Fernandez-Sesma, A., & Frydman, J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 163
- Issue
- 5
- Pages
- 1108-1123
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2163739062
- Cited by
- 270
- References
- 39
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.